University Hospital of Bordeaux - Pellegrin
Bordeaux, 33 076, France
NCT Number: NCT00486577
The purpose of this study is to determine whether chronic electrical stimulation of the primary auditory cortex is effective in the treatment of chronic, severe and intractable tinnitus
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 2 / Phase 3
Bordeaux, 33 076, France
Severe and chronic tinnitus - the perception of sound in one or both ears or in the head when non-external sound is present - can be disabling and difficult to treat. Physiopathology of tinnitus can be considered as similar to neuropathic pain. Neuropathic and central pain are treated since ten years by chronic electrical motor cortex stimulation. The hypothesis of this study is that it will be possible to treat severe tinnitus by this stimulation as neuropathic pains are treated by motor cortical stimulation.
Patient >18 years of age and < 70 years of age Permanent and chronic tinnitus during more than 2 years. A score over 19 at the STI (Quality of life index for tinnitus) Unilateral tinnitus
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
significant chronic primary auditory cortex stimulation during the first two weeks of the follow up than wash out period followed by two weeks of non significant stimulation
non significant stimulation during the first two weeks of the follow up than wash out period followed by two weeks of significant chronic primary auditory cortex stimulation
Time frame: 6 months
Time frame: 6 months
University Hospital, Bordeaux
Other
Acronym: ACOUSCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05034731
Ear Diseases, Hearing Disorders
Aurora, Colorado, United States
View Trial DetailsNCT02811549
Asymmetrical Hearing Loss, Ear Diseases
Sarasota, Florida, United States
View Trial DetailsNCT05467059
Apnea, Dyssomnias
Paris, France
View Trial DetailsNCT04237207
Ear Diseases, Hearing Disorders
Aurora, Colorado, United States
View Trial Details